Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2026-05-29 AGM Information
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
115年年報及股東會資料 — 2026_1786_20260629F13.pdf
AGM Information Classification · 95% confidence The document is titled as the "115年股東常會議事手冊" (115th Annual Shareholders’ Meeting Handbook or meeting manual) and contains the AGM agenda, meeting procedures, attachments (including business report, audit committee report, financial statements, dividend distribution, director nominations, charter amendments, etc.). It is clearly preparatory and presentation materials for the Annual General Meeting rather than the full Annual Report or a simple announcement. Therefore, it should be classified as AGM Information.
2026-05-29 Chinese
115年年報及股東會資料 — 2026_1786_20260629F02.pdf
AGM Information Classification · 92% confidence The document is clearly the full meeting handbook for the company’s 115th Annual General Meeting (“股東常會議事手冊”), containing the meeting procedures, agenda, reports (business report, audit committee report, financial statements), and attachments provided to shareholders at the AGM. This matches our “AGM Information” category, not a regulatory announcement or financial filing itself. Therefore it is classified as AGM Information (AGM-R).
2026-05-29 Chinese
115年年報及股東會資料 — 2026_1786_20260629F17.pdf
Major Shareholding Notification Classification · 90% confidence The document is a statutory disclosure of the top 10 shareholders, listing their shareholdings as of a record date along with related‐party (spouse and family) relationships under accounting standards. This is a standard major shareholding notification rather than a report or announcement of management changes, dividends, or financial results.
2026-05-29 Chinese
115年年報及股東會資料 — 2026_1786_20260629FE2.pdf
AGM Information Classification · 91% confidence The document is a comprehensive meeting handbook for SciVision Biotech’s 2026 General Shareholders’ Meeting. It contains the meeting procedures, agenda items (reports, ratifications, elections, discussions), and detailed attachments (2025 Business Report, Audit Committee’s Review Report, financial statements, auditor’s report, earnings distribution, director candidate list, articles of incorporation amendments, etc.). This is clearly the set of materials distributed for an Annual General Meeting, not merely an earnings release or regulatory notice. Therefore, it matches the AGM Information category.
2026-05-29 English
115年年報及股東會資料 — 2026_1786_20260629FE1.pdf
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a notice for the 2026 General Shareholders’ Meeting, detailing the meeting date, venue, agenda items (reports, ratifications, elections, discussions), dividend appropriation, voting procedures (including electronic voting), and proxy verification. It is sent to shareholders to inform them of the meeting and to facilitate their voting, rather than being the minutes or presentations of the meeting or a full financial report. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-29 English
115年年報及股東會資料 — 2026_1786_20260629F01.pdf
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a notice of the company’s 115th Annual General Meeting (AGM) to shareholders, including agenda items, distribution of proxy forms, voting instructions, solicitation sites, and detailed proxy and agent instructions. It is clearly materials sent to shareholders to provide information and request their votes, fitting the definition of a Proxy Solicitation & Information Statement (PSI), rather than an AGM presentation or the AGM event itself.
2026-05-29 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.